Prevent complications · MICA
Plan vaccine timing and coordinate treatment adjustments.
Sources consulted 16 October 2026 · MICA scientific review to be confirmed
Review influenza, pneumococcal and recombinant zoster vaccination in eligible immunosuppressed adults. Products, boosters and availability follow the applicable national schedule; ACR guidance does not replace it. [1]
After influenza vaccination, ACR conditionally suggests holding methotrexate for 2 weeks if disease activity allows. With rituximab, give influenza vaccine on schedule; time other non-live vaccines when the next course is due, then delay that course by at least 2 weeks if possible. [2]
Generally defer during immunosuppression. Exceptions and treatment interruptions require specialist planning. [1]
Personal reading prompts; no clinical data is recorded.
FICTIONAL LEARNING SCENARIO
Should influenza vaccination be delayed for months during rituximab treatment?
Not routinely: influenza is an exception to the timing used for other non-live vaccines. [2]
Non-exhaustive adult learning guidance. Check indication, contraindications, product information and local context before an individual decision. Cited recommendations do not establish marketing authorisation in Algeria.